Loading...
XSHG600866
Market cap1.37bUSD
Jan 15, Last price  
6.04CNY
1D
-0.82%
1Q
1.85%
Jan 2017
-14.69%
Name

Star Lake Bioscience Co Inc Zhaoqing Guangdong

Chart & Performance

D1W1MN
XSHG:600866 chart
P/E
14.80
P/S
0.58
EPS
0.41
Div Yield, %
0.00%
Shrs. gr., 5y
22.43%
Rev. gr., 5y
82.27%
Revenues
17.28b
-1.17%
457,611,636597,422,825751,907,688768,807,889982,171,0581,366,052,2471,376,879,9271,063,088,4061,091,200,516902,804,493871,491,716729,761,470679,847,503686,969,427859,110,0321,049,609,5311,116,277,2681,235,046,85817,486,316,70417,281,424,560
Net income
678m
-42.69%
39,027,79612,979,25717,276,758029,000,889224,520,604284,993,43987,685,906020,235,1350024,306,189042,280,333149,552,368148,710,264106,469,8801,182,985,176677,954,270
CFO
2.03b
+21.87%
29,052,79346,827,60835,144,37382,277,757148,934,446316,728,554104,629,83865,883,9380002,745,29141,169,38540,050,03450,686,252213,169,117249,985,729192,629,0971,662,506,5692,026,097,966
Dividend
Jun 17, 20240.38 CNY/sh
Earnings
May 13, 2025

Profile

Star Lake Bioscience Co., Inc. manufactures and sells pharmaceutical raw materials, and food and feed additives in China and internationally. The company offers guanosine that is used as an intermediate for food and pharmaceutical raw material; L-proline for use as an intermediate for synthesizing captopril and enalapril, and raw material for amino acid transfusion; adefovir dipivoxil tablets used to reduce the activity of HBV DNA polymerase and anti-virus by destroying Hepatitis B virus DNA; and L-threonine that is used in premixtures, and pig and poultry feed. It also provides disodium 5'-ribonucleotide to cure chronic hepatitis, muscular atrophy, and eye diseases; disodium 5-inosinate to cure leukopenia, thrombocytopenia, and chronic and acute hepatitis; and inosine, which is used for the treatment of chronic hepatitis, heart disease, leukopenia or thrombocytopenia, central choroidoretinitis, etc. In addition, the company offers disodium 5'-guanylate for canned meat, ham, salted meat, etc. Further, it provides ribavirin, adenosine, adenine, memantine hydrochloride, arginine, D-ribose, fructose syrup, L-valine, L-threonine, L-lysine, etc. The company offers its products under the Star Lake and Yue Bao brands. Star Lake Bioscience Co., Inc. was founded in 1964 and is based in Zhaoqing, China.
URL
http://www.starlake.com.cn
IPO date
Aug 18, 1994
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
17,281,425
-1.17%
17,486,317
1,315.84%
Cost of revenue
15,604,708
14,954,930
Unusual Expense (Income)
NOPBT
1,676,716
2,531,387
NOPBT Margin
9.70%
14.48%
Operating Taxes
177,921
240,564
Tax Rate
10.61%
9.50%
NOPAT
1,498,795
2,290,823
Net income
677,954
-42.69%
1,182,985
1,011.10%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
2,447,959
2,949,315
Long-term debt
1,764,203
1,538,718
Deferred revenue
74,539
62,146
Other long-term liabilities
177,916
337,388
Net debt
2,757,154
3,114,265
Cash flow
Cash from operating activities
2,026,098
1,662,507
CAPEX
(375,833)
Cash from investing activities
(858,789)
Cash from financing activities
(701,713)
(606,544)
FCF
1,177,997
(5,688,782)
Balance
Cash
1,424,951
1,373,768
Long term investments
30,056
Excess cash
590,936
499,452
Stockholders' equity
2,856,650
2,289,673
Invested Capital
11,455,013
11,121,979
ROIC
13.28%
34.99%
ROCE
13.74%
21.48%
EV
Common stock shares outstanding
1,661,473
1,187,673
Price
4.66
-21.42%
5.93
-4.97%
Market cap
7,742,462
9.93%
7,042,900
52.73%
EV
10,597,328
10,205,522
EBITDA
2,530,253
3,513,581
EV/EBITDA
4.19
2.90
Interest
182,360
243,290
Interest/NOPBT
10.88%
9.61%